Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.
Clinical trial NCT04381494 · TERMINATED
Trial details
- NCT number
- NCT04381494
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-27
- Primary completion
- 2022-01-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.